Severe Asthma Research Program (SARP)
A National Institutes of Health/ National Heart, Lung & Blood Institutes
sponsored network
Your Subtitle text
University of Pittsburgh Information for Asthmatics and caregivers
PARTICIPATE IN SARP UNIVERSITY OF PITTSBURGH
The University of Pittsburgh site focuses on understanding the role of the small airways in asthma, particularly in relation to changes in the lungs identified on CT scans, the relationship to specific types of inflammation and asthma exacerbations. We have also been actively investigating different subgroups of severe asthma, based on the age that asthma started, the differences in severe asthma in men and women, as well as associated differences in the inflammatory process associated with each subgroup. We believe that a better understanding of these subgroups and the associated large and small airway inflammation will improve our ability to specifically target therapy and improve treatment.
Principal Investigator:
Sally E. Wenzel, MD
Director, Asthma and Allergic Diseases Center
University of PIttsburgh/UPMC
Interested in Participating in SARP?
You will likely qualify for participation in SARP as a severe asthmatic if you:
1. Have been diagnosed with asthma by a physician
2. Require high or continuous doses of asthma medications, such as Advair, Symbicort, prednisone or medrol
3. Still have asthma symptoms on a regular basis
4. Have had frequent or severe exacerbations of asthma (requiring prednisone, ER visits, hospitalizations)
5. Are not currently smoking and have smoked less than 5-10 years total
6. Are between the ages of 6 yrs and 75 yrs of age
You may also qualify for participation in SARP as a “comparative” patient with mild asthma. Similarly, you must be diagnosed with asthma, be between 6 and 75 yrs of age and not be currently smoking or have smoked for more than 5-10 yrs
PARTICIPATE IN SARP UNIVERSITY OF PITTSBURGH
The University of Pittsburgh site focuses on understanding the role of the small airways in asthma, particularly in relation to changes in the lungs identified on CT scans, the relationship to specific types of inflammation and asthma exacerbations. We have also been actively investigating different subgroups of severe asthma, based on the age that asthma started, the differences in severe asthma in men and women, as well as associated differences in the inflammatory process associated with each subgroup. We believe that a better understanding of these subgroups and the associated large and small airway inflammation will improve our ability to specifically target therapy and improve treatment.
Principal Investigator:
Sally E. Wenzel, MD
Director, Asthma and Allergic Diseases Center
University of PIttsburgh/UPMC
Interested in Participating in SARP?
You will likely qualify for participation in SARP as a severe asthmatic if you:
1. Have been diagnosed with asthma by a physician
2. Require high or continuous doses of asthma medications, such as Advair, Symbicort, prednisone or medrol
3. Still have asthma symptoms on a regular basis
4. Have had frequent or severe exacerbations of asthma (requiring prednisone, ER visits, hospitalizations)
5. Are not currently smoking and have smoked less than 5-10 years total
6. Are between the ages of 6 yrs and 75 yrs of age
You may also qualify for participation in SARP as a “comparative” patient with mild asthma. Similarly, you must be diagnosed with asthma, be between 6 and 75 yrs of age and not be currently smoking or have smoked for more than 5-10 yrs
PARTICIPATE IN SARP UNIVERSITY OF PITTSBURGH
